Publications by authors named "Anna C Ferrari"

Claim this Profile
M
Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer.
Christos E Kyriakopoulos, Jens C Eickhoff, Anna C Ferrari, Michael T Schweizer, Ellen Wargowski

Clin Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer.
Anna C Ferrari, Joshi J Alumkal, Mark N Stein, Mary-Ellen Taplin, James Babb

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer.
Anna C Ferrari, Joshi J Alumkal, Mark N Stein, Mary-Ellen Taplin, James Babb

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing resistance to antiandrogens with a histone deacetylase inhibitor.
Anna C Ferrari

Oncotarget· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice.
Monica Bartucci, Anna C Ferrari, Isaac Yi Kim, Alexander Ploss, Martin Yarmush

Front Cell Dev Biol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice.
Monica Bartucci, Anna C Ferrari, Isaac Yi Kim, Alexander Ploss, Martin Yarmush

Front Cell Dev Biol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mithramycin targets sp1 and the androgen receptor transcription level-potential therapeutic role in advanced prostate cancer.
Long G Wang, Anna C Ferrari

Transl Oncogenomics· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
XiaoMei Liu, Alejandro Gomez-Pinillos, Charisse Loder, Enrique Carrillo-de Santa Pau, Ruifang Qiao, Anna C Ferrari

Am J Pathol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR signaling pathway and mTOR inhibitors in cancer therapy.
Alejandro Gomez-Pinillos, Anna C Ferrari

Hematol Oncol Clin North Am· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of surrogate markers in the management of men with metastatic castration-resistant prostate cancer.
Andrew J Armstrong, Anna C Ferrari, David I Quinn

Clin Adv Hematol Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in the treatment of advanced prostate cancer.
Bob Djavan, Kathleen Nelson, Amir Kazzazi, Aron Bruhn, Helen Sadri, Anna C Ferrari

Can J Urol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Philip W Kantoff, Celestia S Higano, Neal D Shore, E Roy Berger, Eric J Small, Anna C Ferrari

N Engl J Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels.
Xiaomei Liu, Alejandro Gomez-Pinillos, Xiaojun Liu, Edward M Johnson, Anna C Ferrari

Prostate· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
Longgui G Wang, Edward M Johnson, Yayoi Kinoshita, James S Babb, Michael T Buckley, Anna C Ferrari

Cancer Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment.
Anna C Ferrari, Nelson N Stone, Ralf Kurek, Elizabeth Mulligan, Roy McGregor

J Clin Oncol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
Long G Wang, Liliana Ossowski, Anna C Ferrari

Oncogene· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biological basis for the use of an anti-androgen and a 5-alpha-reductase inhibitor in the treatment of recurrent prostate cancer: Case report and review.
Long G Wang, Simon K Mencher, J P McCarron, Anna C Ferrari

Oncol Rep· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
13-cis retinoic acid and complete androgen blockade in advanced hormone-naive prostate cancer patients: report of a phase II randomized study.
Anna C Ferrari, Nelson Stone, Richard Stock, Myron Bednar, Isaac Esseesse

J Clin Oncol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis